|
|
|
| HIV-1 Tat Protein Inhibits the Hematopoiesis Support Function of Bone Marrow Mesenchymal Stem Cells |
| YUAN Ya-hong1,2, ZHAO Shan-shan2, WANG Xiao-li1,2, TENG Zhi-ping3, LI Dong-sheng2, ZENG Yi1 |
1. Department of Biomedical Engineering, Beijing University of Technology, Beijing 100124, China;
2. Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China;
3. Institute of Virology, Chinese Academy of Preventive Medicine, Beijing 100052, China |
|
|
|
Abstract Objective:In order to further reveal the mechanism of hematopoietic injury among people infected with HIV-1, The effect of HIV-1 Tat protein on hematopoiesis support function of bone marrow mesenchymal stem cells(BMSC) was researched. Methods:The bone marrow mesenchymal stem cells were primary cultured and their characters were identified by detecting differentiation potential and immune phenotype. Hematopoietic stem cells (HSC) were sorted with immunomagnetic beads and the purity were detected with flow cytometry. As the feeder layer, the control BMSC (BMSCCon) and the experiment BMSC which have been added HIV-1Tat protein into the medium for culturing 20 days (BMSCTat) were respectively co-cultured with HSC and divided into six groups. Then, a series of detections were carried out, the total numbers of hematopoietic cells were counted, hematopoietic cells clonogenic ability were assayed, hematopoietic growth fator mRNA expression of BMSCCon and BMSCTat were detected with RT-PCR, GM-CSF and IL-6 concentration in the condition medium of BMSCCon and BMSCTat were detected with ELISA. Results:Identification results show that the BMSC were successfully cultured.The purity of HSC sorted by immunomagnetic beads can reach more than 95%. The six groups were compared with each other and the results showed that both the total numbers of hematopoietic cells and the total numbers of hematopoietic cell colony in the groups when BMSCTat were as the feeder layer were significantly less than those in the groups when BMSCCon were as the feeder layer. The hematopoietic growth fator mRNA expression of BMSCTat were significantly weaker than that of BMSCCon. The GM-CSF and IL-6 concentration in the condition medium of BMSCTat were significantly lower than that of BMSCCon. Conclusions:The HIV1 Tat protein was confirmed to inhibit the hematopoiesis support function of bone marrow mesenchymal stem cells.
|
|
Received: 26 December 2016
Published: 25 June 2017
|
|
|
|
|
[1] Zon L I, Groopman J E. Hematologic manifestations of the human immune deficiency virus (HIV). Seminars in Hematology, 1988, 25(3):208-218.
[2] Scadden D T, Zon L I, Groopman J E. Pathophysiology and management of HIV-associated hematologic disorders. Blood, 1989, 74(5):1455-1463.
[3] Redig A J, Berliner N. Pathogenesis and clinical implications of HIV-related anemia in 2013. Hematology Am Soc Hematol Educ Program, 2013, 2013:377-381.
[4] Beaupere C, Garcia M, Larghero J, et al. The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation. Aging Cell, 2015, 14(4):543-546.
[5] Gibellini D, Miserocchi A, Tazzari P L, et al. Analysis of the Effects of HIV-1 Tat on the Survival and Differentiation of Vessel Wall-Derived Mesenchymal Stem Cells. Journal of Cellular Biochemistry, 2012, 113(4):1132-1141.
[6] Ludwig A, Saffrich R, Eckstein V, et al. Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor. Cytotherapy, 2014, 16(1):111-121.
[7] Pelagiadis I, Stiakaki E, Choulaki C, et al. The role of children's bone marrow mesenchymal stromal cells in the ex vivo expansion of autologous and allogeneic hematopoietic stem cells. Cell Biology International, 2015, 39(10):1099-1110.
[8] Freida D, Lecourt S, Cras A, et al. Human bone marrow mesenchymal stem cells regulate biased DNA segregation in response to cell adhesion asymmetry. Cell Rep, 2013, 5(3):601-610.
[9] Davis B R, Zauli G. Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin Haematol, 1995, 8(1):113-130.
[10] Sebastian N T, Collins K L. Targeting HIV latency:resting memory T cells, hematopoietic progenitor cells and future directions. Expert Review of Anti-Infective Therapy, 2014, 12(10):1187-1201.
[11] Kuller L H, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine, 2008, 5(10):e203.
[12] Bahner I, Kearns K, Coutinho S, et al. Infection of human marrow stroma by human immunodeficiency virus-1(HIV-1) is both required and sufficient for HIV-1- induced hematopoietic suppression in vitro:demonstration by gene modification of primary human stroma. Blood, 1997, 90(5):1787-1798.
[13] Mcnamara L A, Onafuwa-nuga A, Sebastian N T, et al. CD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppression. J Infect Dis, 2013, 207(12):1807-1816.
[14] Kyei G B, Dinkins C, Davis A S, et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol, 2009, 186(2):255-268.
[15] Raymond A D, Campbell-sims T C, Khan M, et al. HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses, 2011, 27(2):167-178.
[16] Cotter E J, Malizia A P, Chew N, et al. HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses, 2007, 23(12):1521-1530.
[17] Cotter E J, Chew N, Powderly W G, et al.HIV type 1 alters mesenchymal stem cell differentiation potential and cell phenotype ex vivo. AIDS Res Hum Retroviruses, 2011, 27(2):187-199.
[18] Gibellini D, De Crignis E, Ponti C, et al. HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. Biochem Biophys Res Commun, 2010, 401(3):429-434.
[19] Gibellini D, Miserocchi A, Tazzari P L, et al. Analysis of the Effects of HIV-1 Tat on the Survival and Differentiation of Vessel Wall-Derived Mesenchymal Stem Cells. J Cell Biochem, 2012,113(4):1132-1141.
[20] Kallekleiv M, Larun L, Bruserud O, et al. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation:A systematic review and meta-analysis. Cytotherapy, 2016, 18(2):172-185.
[21] Hutter G, Nowak D, Mossner M, et al.Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med, 2009, 360(7):692-698.
[22] Younan P, Kowalski J, Kiem H P, et al. Genetic modification of hematopoietic stem cells as a therapy for HIV/AIDS. Viruses, 2013, 5(12):2946-2962. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
